Cord blood transplantation from unrelated donors for children with acute lymphoblastic leukemia in japan: The impact of methotrexate on clinical outcomes

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 12, 2011, Pages 1814-1821

  Kato, Koji ^a   Yoshimi, Ayami ^b,o   Ito, Etsuro ^c   Oki, Kentaro ^d,p   Hara, Juinichi ^e   Nagatoshi, Yoshihisa ^f,g   Kikuchi, Akira ^g,q   Kobayashi, Ryoji ^h,r   Nagamura Inoue, Tokiko ⁱ   Kai, Shunro ^j   Azuma, Hiroshi ^k   Takanashi, Minoko ^l   Isoyama, Keiichi ^m   Kato, Shunichi ⁿ  

^a JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

^d CHIBA UNIVERSITY HOSPITAL   (Japan)

^e OSAKA CITY GENERAL HOSPITAL   (Japan)

^f NATIONAL KYUSHU CANCER CENTER   (Japan)

^g SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^h HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ Tokyo Cord Blood Bank   (Japan)

^j Hyogo College of Medicine   (Japan)

^k Hokkaido Cord Blood Bank   (Japan)

^l The Metro Tokyo Cord Blood Bank   (Japan)

^m Kanagawa Cord Blood Bank   (Japan)

ⁿ TOKAI UNIVERSITY   (Japan)

^o UNIVERSITY OF FREIBURG   (Germany)

^p UNIVERSITY OF TOKYO   (Japan)

^q TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^r SAPPORO HOKUYU HOSPITAL   (Japan)

more..

Author keywords

Acute lymphoblastic leukemia; Cord blood transplantation; HLA; Methotrexate

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; PREDNISOLONE; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADVANCED CANCER; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CHRONIC GRAFT VERSUS HOST DISEASE; CORD BLOOD STEM CELL TRANSPLANTATION; EVENT FREE SURVIVAL; FEMALE; HUMAN; INCIDENCE; JAPAN; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROPHYLAXIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; TREATMENT OUTCOME; WHOLE BODY RADIATION;

BLOOD PLATELETS; CHILD; CHILD, PRESCHOOL; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; HUMANS; INFANT, NEWBORN; JAPAN; MALE; METHOTREXATE; NEUTROPHILS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; UNRELATED DONORS; WHOLE-BODY IRRADIATION;

EID: 81255185235     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.05.013     Document Type: Article

References (31)

1. Pui C.H., Relling M.V., Downing J.R. Acute lymphoblastic leukemia. N Engl J Med 2004, 350:1535-1548.
2. Möricke A., Reiter A., Zimmermann M., et al. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood 2008, 111:4477-4489.
3. Balduzzi A., Valsecchi M.G., Uderzo C., et al. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study. Lancet 2005, 366:635-642.
4. Aricò M., Valsecchi M.G., Camitta B., et al. Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med 2000, 342:998-1006.
5. Schrauder A., von Stackelberg A., Schrappe M., Cornish J., Christiana P. Allogeneic hematopoietic SCT in children with ALL: current concepts of ongoing prospective SCT trials. Bone Marrow Transplant 2008, 41:S71-S74.
6. Kosaka Y., Koh K., Kinukawa N., et al. Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation. Blood 2004, 104:3527-3534.
7. Rocha V., Cornish J., Sievers E.L., et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001, 97:2962-2971.
8. MacMillan M.L., Davies S.M., Nelson G.O., Chitphakdithai P., Confer D.L., King R.J. Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program. Biol Blood Marrow Transplant 2008, 14:16-22.
9. Hough R., Labopin M., Michel G., et al. Outcomes of fully haplo-identical haematopoietic stem cell transplantation compared to unrelated cord blood transplantation in children with acute lymphoblastic leukaemia. A retrospective analysis on behalf of Eurocord, PDWP and ALWP of EBMT. Bone Marrow Transplant 2007, 39:S3.
10. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974, 18:295-304.
11. Gluckman E., Rocha V. Acute Leukemia Working Parties and Eurocord. Indications and results of cord blood transplant in children with leukemia. Bone Marrow Transplant 2008, 41:S80-S82. on the behalf of EBMT Paediatric.
12. Gluckman E., Rocha V. Cord blood transplantation for children with acute leukaemia: a Eurocord registry analysis. Blood Cells Mol Dis 2004, 33:271-273.
13. Ruggeri, Dalle J.-H., Michel G., et al. Outcomes of unrelated cord blood transplant in children with acute lymphoblastic leukaemia. A survey by EUROCORD and the Acute Leukaemia and Pediatric Disease Working Parties of the EBMT. Bone Marrow Transplant 2010, 45:S49.
14. Wagner J.E., Barker J.N., DeFor T.E., et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002, 100:1611-1618.
15. Kurtzberg J., Prasad V.K., Carter S.L., et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood 2008, 112:4318-4327.
16. Sawczyn K.K., Quinones R., Malcolm J., et al. Cord blood transplant in childhood ALL. Pediatr Blood Cancer 2005, 45:964-970.
17. Eapen M., Rubinstein P., Zhang M.J., et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 2007, 369:1947-1954.
18. Gluckman E., Koegler G., Rocha V. Human leukocyte antigen matching in cord blood transplantation. Semin Hematol 2005, 42:85-90.
19. Kurtzberg J., Laughlin M., Graham M.L., et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996, 335:157-166.
20. Wall D.A., Carter S.L., Kernan N.A., et al. Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience. Biol Blood Marrow Transplant 2005, 11:637-646.
21. Rubinstein P., Carrier C., Scaradavou A., et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998, 339:1565-1577.
22. Gluckman E., Rocha V., Arcese W., et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004, 32:397-407.
23. Kishi Y., Kami M., Miyakoshi S., et al. Early immune reaction after reduced-intensity cord-blood transplantation for adult patients. Transplantation 2005, 80:34-40.
24. Nishihira H., Kato K., Isoyama K., et al. The Japanese cord blood bank network experience with cord blood transplantation from unrelated donors for haematological malignancies: an evaluation of graft-versus-host disease prophylaxis. Br J Haematol 2003, 120:516-522.
25. Rocha V., Wagner J.E., Sobocinski K.A., et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000, 342:1846-1854.
26. Locatelli F., Rocha V., Chastang C., et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. Blood 1999, 93:3662-3671.
27. Finke J., Bethge W.A., Schmoor C., et al. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. Lancet Oncol 2009, 10:855-864.
28. Narimatsu H., Terakura S., Matsuo K., Oba T., Uchida T., Iida H., et al. Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults. Bone Marrow Transplant 2007, 39:31-39.
29. Terakura S., Azuma E., Murata M., et al. Hematopoietic engraftment in recipients of unrelated donor umbilical cord blood is affected by the CD34+ and CD8+ cell doses. Biol Blood Marrow Transplant 2007, 13:822-830.
30. Takahashi S., Iseki T., Ooi J., Tomonari A., Takasugi K., Shimohakamada Y., et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood 2004, 104:3813-3820.
31. Isoyama K., Oda M., Kato K., et al. Long-term outcome of cord blood transplantation from unrelated donors as an initial transplantation procedure for children with AML in Japan. Bone Marrow Transplant 2010, 45:69-77.